2006
DOI: 10.1080/00016480510038563
|View full text |Cite
|
Sign up to set email alerts
|

Protective effect of edaravone against the ototoxicity ofPseudomonas aeruginosaexotoxin A

Abstract: PaExoA had penetrated from the middle ear into the cochlea and caused hearing loss. This impairment was blocked by intratympanic injection of edaravone when given simultaneously or 1 h after the first instillation of PaExoA, or by intravenous injection of edaravone when given simultaneously. There were significant differences in protective effect between the intratympanic and intravenous routes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0

Year Published

2009
2009
2015
2015

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 21 publications
0
12
0
Order By: Relevance
“…Although edaravone is rather a safe agent when administered to the patients (Takumida and Anniko, 2006), its clinical application in cisplatin-induced ototoxicity remains unclear, because the problem as to whether edaravone enhances or suppresses the efficacy of cisplatin in the treatment of cancer cells remains unsettled yet. Also, since our experiment was conducted with an HEI-OC1 cell line, its conditions are not typical condition of cochlear cells as it is cultured under permissive conditions (33.8 C, 10% CO2).…”
Section: Discussionmentioning
confidence: 97%
See 2 more Smart Citations
“…Although edaravone is rather a safe agent when administered to the patients (Takumida and Anniko, 2006), its clinical application in cisplatin-induced ototoxicity remains unclear, because the problem as to whether edaravone enhances or suppresses the efficacy of cisplatin in the treatment of cancer cells remains unsettled yet. Also, since our experiment was conducted with an HEI-OC1 cell line, its conditions are not typical condition of cochlear cells as it is cultured under permissive conditions (33.8 C, 10% CO2).…”
Section: Discussionmentioning
confidence: 97%
“…Edaravone is a neuroprotective agent with potent free radical scavenging and antioxidant actions without causing any serious side effects (Takumida and Anniko, 2006;Higashi et al, 2006). Edaravone is reported to reduce the amount of oxidative DNA damage (Maekawa et al, 2009) and decrease the amount of ROS Fig.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…ROS scavengers have been shown to protect the inner ear from the deleterious effects of aminoglycosides [6], cisplatin [7], bacterial toxin [8], and acoustic trauma [9]. There is accumulating research evidence that the free radicals may play an important role in the inner ear and antioxidants can be used not only for the prevention of but also for treatment of inner ear disorders [10].…”
Section: Introductionmentioning
confidence: 98%
“…The generation of ROS is an important mechanism of inner ear damage and ototoxicity [1,16,19]. An excess of ROS can induce apoptotic cell death.…”
Section: Discussionmentioning
confidence: 99%